PBM PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

PBM ▼ -59.20% at T+20d

NEUTRAL call ✗ call lost -59.20% · α vs SPY -63.41% · entry $11.30 → $4.61

Next anchor: T+60d in 7w

Last close $4.10 (close May 22) · -63.72% from $11.30 entry

Entry anchored
Apr 20, 07:41 AM ET
via Databento tick

T+1d

-16.02%

call -16.02% · α -15.36%

$9.49

settled 5w ago

T+5d

-37.61%

call -37.61% · α -38.52%

$7.05

settled 27d ago

T+20d

-59.20%

call -59.20% · α -63.41%

$4.61

settled 6d ago

T+60d

—

call — · α —

—

in 7w

Price Chart

Loading chart...

Executive Summary

Psyence Biomedical Ltd. announced advancements in its vertically integrated ibogaine supply chain through its subsidiary PsyLabs, highlighting GMP-compliant inventory and manufacturing capabilities to support clinical research. The press release emphasizes strategic positioning amid growing regulatory interest but contains no new financial or clinical data.

Actionable Insight

Monitor for future announcements of research partnerships or supply agreements that could validate commercial traction. Absent near-term material contracts, the current announcement is largely preparatory and promotional.

Key Facts

Company highlighted GMP-compliant ibogaine inventory and vertically integrated supply chain via PsyLabs.
No specific financial figures, revenue, or deal values disclosed.
Emphasis on readiness to support clinical research as regulatory pathways evolve.
Forward-looking statements dominate; no confirmed contracts, partnerships, or commercial sales announced.

Financial Impact

No quantifiable financial impact disclosed

Risk Factors

Forward-looking statements carry high uncertainty; actual regulatory or clinical progress may not materialize.
Lack of disclosed revenue or customer contracts limits near-term commercial credibility.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3276903

2 reports for PBM

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for PBM — sortable, filterable
	Type				Now
Apr 23, 2026 4w ago	Press Release BULLISH ★ 7/10	$9.03 $4.01	▼ −55.59%	▼ −60.23%	$4.10 (−54.60%)
Apr 20, 2026 4w ago	Press Release NEUTRAL ★ 3/10	$11.30 $4.61	▼ −59.20%	▼ −63.41%	$4.10 (−63.72%)

US Market Status

Market Closed — Opens Tue (34h 51m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access